Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

According to proxy adviser Institutional Shareholder Services, Procter & Gamble shareholders should vote in favor of activist investor Nelson Peltz joining the companys board. Procter & Gambles annual shareholder meeting is scheduled on October 10th.

Procter & Gamble shares closed higher for a second consecutive trading session on Friday. The stock edged up 0.10% ($0.09) to $90.98, after touching an intraday high at $91.43, or a price level not seen since September 27th ($92.52). In the week ended on October 1st the shares of the consumer goods provider lost 1.37% of their market value compared to a week ago, which marked a second consecutive period of decline and also the worst performance since the week ended on July 2nd. The stock retreated 1.40% in September, which marked the first loss since June. For the entire past year, Procter & Gamble shares gained 5.88%. The stock has risen 8.21% so far in 2017.

“The addition of one well-qualified nominee, who holds a large economic stake, appears likely to have benefits that outweigh the potential risks”, ISS said on Friday, cited by Reuters. “Support for dissident nominee Peltz is recommended.”

Peltzs nomination to Procter & Gambles board was announced earlier this year. Additionally, Peltzs Trian Fund Management revealed a $3.5 billion stake in the consumer goods giant.

There have been opinions that Peltzs plan aimed at increasing shareholder value through restructuring the company into three autonomous business units would lead to higher expenses, lower profits and a potential need for further re-organization.

According to CNN Money, the 21 analysts, offering 12-month forecasts regarding Procter & Gamble’s stock price, have a median target of $95.00, with a high estimate of $106.00 and a low estimate of $80.00. The median estimate is a 4.42% surge compared to the closing price of $90.98 on September 29th.

The same media also reported that 12 out of 25 surveyed investment analysts had rated Procter & Gamble’s stock as “Hold”, while 9 – as “Buy”. On the other hand, 2 analysts had recommended selling the stock.

Daily and Weekly Pivot Levels

With the help of the Camarilla calculation method, todays levels of importance for the Procter & Gamble stock are presented as follows:

R1 – $91.05
R2 – $91.11
R3 (Range Resistance – Sell) – $91.18
R4 (Long Breakout) – $91.38
R5 (Breakout Target 1) – $91.62
R6 (Breakout Target 2) – $91.71

S1 – $90.91
S2 – $90.85
S3 (Range Support – Buy) – $90.78
S4 (Short Breakout) – $90.58
S5 (Breakout Target 1) – $90.34
S6 (Breakout Target 2) – $90.25

By using the traditional method of calculation, the weekly levels of importance for Procter & Gamble Company (PG) are presented as follows:

Central Pivot Point – $91.47
R1 – $92.60
R2 – $94.22
R3 – $95.35
R4 – $96.48

S1 – $89.85
S2 – $88.72
S3 – $87.10
S4 – $85.48

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Spot Gold extends losses as hot CPI dims Fed cut hopesSpot Gold extends losses as hot CPI dims Fed cut hopes Spot Gold extended its slide on Wednesday after the latest US inflation figures dampened hopes of Federal Reserve interest rate cuts.Uncertainty in the Middle ‌East also weighed on the metal. The backdrop in the region remains unsettled […]
  • AUD/USD retreats from one-month highs ahead of US retail sales reportAUD/USD retreats from one-month highs ahead of US retail sales report Australian dollar slid from highs unseen in a month against its US counterpart on Tuesday ahead of the release of US retail sales report later in the day, while the Aussie may be tempered also ahead of the employment data, due out on January […]
  • Roche share price up, to partner up with Foundation against cancerRoche share price up, to partner up with Foundation against cancer Roche Holding AG agreed to acquire a majority stake in Foundation Medicine Inc for more than $1 billion, increasing its presence in cancer treatment.The Swiss drugmaker said on Monday that it will enter a strategic collaboration with […]
  • Symantec Corp. expects its revenue to trail analysts’ estimatesSymantec Corp. expects its revenue to trail analysts’ estimates Symantec Corp. announced that it expects a revenue that trails some analysts estimates amid declines in the personal-computer market and the emergence of advanced hacking threats influenced on traditional antivirus software demand.Symantec […]
  • Iron ore falls amid lower demandIron ore falls amid lower demand Iron ore prices are experiencing pressure by lowered demand from China. The IMF cut its economy growth forecast for China to 7.75%, down from 8%. The Organisation for Economic Co-operation and Development also trimmed its forecast to 7,8% from […]
  • Kiwi Dollar Climbs as Chinese Services Data Tops ForecastsKiwi Dollar Climbs as Chinese Services Data Tops Forecasts Key Moments NZD/USD traded near 0.5860 in early Asian dealings, ending a four-day losing streak. China’s RatingDog Services PMI rose to 51.4 in August, beating both July’s 50.4 reading and the 50.6 consensus. Hawkish […]